Dark

DXCM
DexCom, Inc.
stock NASDAQ

Market Open

Jun 30, 2026 1:12:39 PM EDT

68.34USD-2.344%(-1.64)1,632,076

68.29Bid 71.65Ask 3.36Spread

Pre-market

Jun 30, 2026 9:28:30 AM EDT

69.71USD-0.386%(-0.27)758

After-hours

Jun 29, 2026 4:06:30 PM EDT

69.98USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 19, 2022

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 Benzinga

07:27AM EST 10 Biggest Price Target Changes For Wednesday Benzinga

06:18AM EST Wells Fargo Upgrades DexCom to Overweight, Announces $575 Price Target Benzinga

04:55AM EST Raymond James Maintains Outperform on DexCom, Lowers Price Target to $538 Benzinga

Jan 10, 2022

07:53AM EST Dexcom Sees Q4 Sales ~$698M Vs. $696.47M Est. Benzinga

Jan 7, 2022

01:08PM EST Where DexCom Stands With Analysts Benzinga

01:07PM EST Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 Benzinga

01:04PM EST Morgan Stanley Maintains Equal-Weight on DexCom, Lowers Price Target to $570 Benzinga

01:04PM EST Guggenheim Upgrades DexCom to Buy, Announces $580 Price Target Benzinga

Jan 4, 2022

08:45AM EST Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference Business Wire

Nov 29, 2021

08:45AM EST Dexcom Announces Upcoming Conference Presentation Business Wire

Nov 22, 2021

04:04PM EST Dexcom Filing Shows Registration For Mixed Securities Shelf Offering, No Size Disclosed Benzinga

Nov 3, 2021

12:25PM EDT Expert Ratings For DexCom Benzinga

10:24AM EDT Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $750 Benzinga

Nov 1, 2021

12:19PM EDT Where DexCom Stands With Analysts Benzinga

07:42AM EDT 10 Biggest Price Target Changes For Monday Benzinga

04:53AM EDT Raymond James Maintains Outperform on DexCom, Raises Price Target to $618 Benzinga

Oct 29, 2021

12:15PM EDT What 4 Analyst Ratings Have To Say About DexCom Benzinga

12:14PM EDT UPDATE: SVB Leerink On DexCom Price Target Raise: Firm Highlights 'Still-Strong & Maybe Even Improving Fundamentals' Given Global Sales Growth Over Abbott Despite Continued Channel Mix Headwinds; Positive On Another Quarter Of 40%+ Volume Growth Benzinga

07:47AM EDT Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $576 Benzinga

07:32AM EDT 10 Biggest Price Target Changes For Friday Benzinga

06:25AM EDT SVB Leerink Maintains Outperform on DexCom, Raises Price Target to $715 Benzinga

Oct 28, 2021

04:43PM EDT Recap: DexCom Q3 Earnings Benzinga

04:23PM EDT Dexcom Raises FY21 Sales Guidance From $2.35B-$2.4B To $2.425B-$2.45B vs $2.4B Estimate Benzinga

04:22PM EDT DexCom Q3 Adj. EPS $0.89 Beats $0.63 Estimate, Sales $650.20M Beat $617.82M Estimate Benzinga

04:08AM EDT Earnings Scheduled For October 28, 2021 Benzinga

Oct 18, 2021

12:56PM EDT Analyst Ratings For DexCom Benzinga

10:22AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2021 Benzinga

09:14AM EDT Guggenheim Downgrades DexCom to Neutral Benzinga

Oct 5, 2021

08:45AM EDT Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time Business Wire

Sep 29, 2021

06:03AM EDT Dexcom Announces G6 Continuous Glucose Monitoring System Now Covered In Manitoba For Young People With Type 1 Diabetes Benzinga

Sep 23, 2021

07:57AM EDT The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data Benzinga

Sep 17, 2021

07:36AM EDT The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold Benzinga

Sep 16, 2021

01:22PM EDT Expert Ratings For DexCom Benzinga

06:23AM EDT Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $650 Benzinga

Sep 13, 2021

01:00PM EDT Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adolescents on Intensive Insulin Therapy Business Wire

Sep 10, 2021

08:00AM EDT The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test Benzinga

Sep 9, 2021

08:17AM EDT The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization Benzinga

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Sep 2, 2021

08:45AM EDT Dexcom Announces Upcoming Virtual Conference Presentations Business Wire

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Sep 1, 2021

07:32AM EDT The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering Benzinga

Aug 27, 2021

07:35AM EDT The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration Benzinga

Aug 5, 2021

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

Aug 2, 2021

02:28PM EDT Dexcom Stock Jumps As Q2 Earnings Beats Street, Raises Guidance; Analysts Bump Up Target Price Benzinga

01:18PM EDT Expert Ratings for DexCom Benzinga

08:57AM EDT Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $510 Benzinga

Jul 30, 2021

01:38PM EDT UPDATE: Raymond James On Dexcom Price Target Raise Post-Earnings: Firm Highlights 'Record Number Of New Users In 2Q' With New Contracting In Europe To Drive Faster New User Starts In 2H21; Sees Physicians Prescribing Co. Doubling Over Last 18 Months Benzinga

01:23PM EDT Dexcom Stock Jumps As Q2 Earnings Beats Street, Raises Guidance; Analysts Bump Up Target Price Benzinga

12:15PM EDT Where DexCom Stands With Analysts Benzinga

10:49AM EDT Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $550 Benzinga

10:06AM EDT Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $500 Benzinga

10:04AM EDT Oppenheimer Maintains Outperform on DexCom, Raises Price Target to $525 Benzinga

08:27AM EDT Raymond James Maintains Outperform on DexCom, Raises Price Target to $515 Benzinga

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

07:44AM EDT 10 Biggest Price Target Changes For Friday Benzinga

07:38AM EDT Wells Fargo Maintains Equal-Weight on DexCom, Raises Price Target to $475 Benzinga

04:47AM EDT SVB Leerink Maintains Outperform on DexCom, Raises Price Target to $500 Benzinga

Jul 29, 2021

04:51PM EDT Recap: DexCom Q2 Earnings Benzinga

04:24PM EDT DexCom Sees FY21 Sales $2.35B-$2.4B vs $2.34B Estimate Benzinga

04:24PM EDT DexCom Q2 Adj. EPS $0.76 Beats $0.45 Estimate, Sales $595.10M Beat $551.27M Estimate Benzinga

08:18AM EDT The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs Benzinga

04:23AM EDT Earnings Scheduled For July 29, 2021 Benzinga

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 15, 2021

04:52PM EDT DexCom Says FDA Clears Co's Real-Time APIs For Third-Party Apps And Devices Benzinga

Jun 29, 2021

08:25AM EDT Watching Insulin Manufacturers After Walmart Announces Private Brand Analog Insulin Benzinga

Jun 18, 2021

07:46AM EDT Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic Benzinga

Jun 1, 2021

06:21AM EDT Saskatchewan Health To Cover Dexcom G6 Continuous Glucose Monitoring System For People With Diabetes Under Age Of 18 RTTNews

06:00AM EDT Saskatchewan Health to Cover Dexcom G6 Continuous Glucose Monitoring System for PR Newswire

May 28, 2021

10:21AM EDT Where DexCom Stands With Analysts Benzinga

10:10AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 28, 2021 Benzinga

06:22AM EDT Wells Fargo Upgrades DexCom to Equal-Weight, Announces $380 Price Target Benzinga

May 27, 2021

08:45AM EDT Dexcom Announces Upcoming Conference Presentation Business Wire

May 26, 2021

06:11AM EDT RAMQ Now Offers Provincial Coverage Of The Dexcom G6 Continuous Glucose Monitoring System For Type 1 Diabetes In Quebec RTTNews

06:00AM EDT RAMQ Now Offers Provincial Coverage of The Dexcom G6 Continuous Glucose PR Newswire

May 25, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 Benzinga

06:52AM EDT Barclays Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $500 Benzinga

Apr 30, 2021

09:22AM EDT Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $455 Benzinga

08:09AM EDT Raymond James Maintains Outperform on DexCom, Raises Price Target to $466 Benzinga

07:31AM EDT The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs Benzinga

07:12AM EDT Citigroup Maintains Buy on DexCom, Raises Price Target to $488 Benzinga

Apr 29, 2021

04:48PM EDT Recap: DexCom Q1 Earnings Benzinga

04:27PM EDT DexCom Sees FY21 Sales $2.26B-$2.36B Vs. $2.32B Est. Benzinga

04:26PM EDT DexCom Q1 EPS $0.41 Beats $0.30 Estimate, Sales $505.00M Beat $484.23M Estimate Benzinga

04:02PM EDT Dexcom Reports First Quarter 2021 Financial Results Business Wire

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

04:10AM EDT Earnings Scheduled For April 29, 2021 Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 20, 2021

09:25AM EDT Dexcom Says Co's G6 CGM System Approved For Back of Upper Arm Wear Benzinga

09:00AM EDT Dexcom G6 CGM System Approved for Back of Upper Arm Wear, Offering Adults with PR Newswire

Apr 15, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021 Benzinga

06:36AM EDT Atlantic Equities Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $438 Benzinga

Apr 1, 2021

04:15PM EDT Dexcom Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021 at 4:30 p.m. Eastern Time Business Wire

Mar 23, 2021

08:47AM EDT DexCom Reports Promotion Of Jereme Sylvain To CFO Benzinga

Feb 17, 2021

08:45AM EST Dexcom Announces Upcoming Virtual Conference Presentations Business Wire

Feb 12, 2021

10:59AM EST Mid-Morning Market Update: US Stock Futures Trend Down; Nasdaq Composite Dips 0.2% Benzinga

09:52AM EST Citigroup Maintains Buy on DexCom, Lowers Price Target to $480 Benzinga

08:16AM EST Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $410 Benzinga

07:29AM EST Raymond James Maintains Outperform on DexCom, Raises Price Target to $449 Benzinga

Feb 11, 2021

04:19PM EST Recap: DexCom Q4 Earnings Benzinga

04:10PM EST Dexcom Launches Inaugural Venture Capital Fund Business Wire

04:03PM EST Dexcom Sees FY21 Sales $2.21B-$2.31B vs $2.33B Est. Benzinga

04:02PM EST DexCom Q4 Adj. EPS $0.91 Misses $0.92 Estimate, Sales $568.90M Beat $552.23M Estimate Benzinga

04:02PM EST Dexcom Reports Fourth Quarter and Fiscal Year 2020 Financial Results Business Wire

03:51AM EST Earnings Scheduled For February 11, 2021 Benzinga

Feb 10, 2021

10:38AM EST Earnings Preview: DexCom Benzinga

Feb 9, 2021

06:33PM EST Nick Jonas, Bruce Springsteen, Scissorhands And More: Which Super Bowl Commercial Drew The Most Interest? Benzinga

Jan 19, 2021

08:31AM EST Dexcom Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 11, 2021 at 4:30 p.m. Eastern Time Business Wire

Jan 11, 2021

07:46AM EST Dexcom Sees Q4 Sales Exceeding $567M Vs. $550.73M Est. Benzinga

07:45AM EST DexCom Expects Q4 Revenue To Meet Or Exceed $567 Mln, Increase Of 23% Over Last Year RTTNews

07:30AM EST Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2020 and Provides Initial 2021 Outlook Business Wire

Jan 5, 2021

08:30AM EST Dexcom to Present at 39th Annual J.P. Morgan Healthcare Conference Business Wire

Dec 15, 2020

11:48AM EST Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $402 Benzinga

Dec 10, 2020

10:24AM EST Canaccord Genuity Maintains Buy on DexCom, Lowers Price Target to $435 Benzinga

Nov 25, 2020

07:30AM EST Cramer Gives His Opinion On CBAK Energy Technology, Centene And More Benzinga

Nov 12, 2020

08:45AM EST Dexcom Announces Upcoming Virtual Conference Presentations Business Wire

Nov 3, 2020

10:18AM EST Dexcom to Host Investor Day on December 9, 2020 Business Wire

Oct 29, 2020

06:46AM EDT Cramer Weighs In On DexCom, Quidel And Gan Benzinga

Oct 28, 2020

11:32AM EDT Canaccord Genuity Maintains Buy on DexCom, Lowers Price Target to $475 Benzinga

11:00AM EDT Stifel Maintains Buy on DexCom, Lowers Price Target to $475 Benzinga

10:01AM EDT Shares of DexCom, Inc. (DXCM) are currently slipping over 10% despite the medical device company's third-quarter results beating Wall Street estimates. U.S. stocks are trading down on Wednesday morning as investors are worried about the economic impact of spike in coronavirus cases lately. RTTNews

08:23AM EDT Raymond James Maintains Outperform on DexCom, Lowers Price Target to $438 Benzinga

07:43AM EDT Morgan Stanley Maintains Equal-Weight on DexCom, Lowers Price Target to $398 Benzinga

Oct 27, 2020

04:34PM EDT Recap: DexCom Q3 Earnings Benzinga

04:13PM EDT DexCom Q3 EPS $0.73 Beats $0.64 Estimate, Sales $500.90M Beat $476.75M Estimate Benzinga

04:03PM EDT Dexcom Reports Third Quarter 2020 Financial Results Business Wire

10:29AM EDT Shares of DexCom, Inc. (DXCM), a medical device company, are losing almost 6 percent or $24.77 in Tuesday's morning trade at $393.23. RTTNews

08:25AM EDT The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings Benzinga

04:18AM EDT Earnings Scheduled For October 27, 2020 Benzinga

Oct 26, 2020

04:47PM EDT DexCom: Rick Doubleday, EVP And Chief Commercial Officer, To Retire At The End Of 2020 RTTNews

04:43PM EDT Dexcom Reports Q3 Sales $500.9M vs $476.8M Estimate Benzinga

04:42PM EDT Dexcom Announces Retirement of Rick Doubleday and Pre-Announcement of Third Quarter 2020 Revenue Business Wire

Oct 13, 2020

08:35AM EDT Dexcom Appoints Kyle Malady To Board Of Directors RTTNews

Oct 7, 2020

06:33AM EDT Lilly And Dexcom Team Up On New Program For U.S. Healthcare Providers About Rapid-acting Mealtime Insulin Lyumjev RTTNews

06:30AM EDT Lilly and Dexcom team up on new program to help improve diabetes management PR Newswire

Oct 2, 2020

10:39AM EDT Benzinga's Top Upgrades, Downgrades For October 2, 2020 Benzinga

08:11AM EDT 10 Biggest Price Target Changes For Friday Benzinga

06:05AM EDT Wells Fargo Downgrades DexCom to Underweight, Lowers Price Target to $350 Benzinga

Oct 1, 2020

08:30AM EDT Dexcom Schedules Third Quarter 2020 Earnings Release and Conference Call for October 27, 2020 at 4:30 p.m. Eastern Time. Business Wire

Sep 24, 2020

08:35AM EDT Dexcom Signs Multi-Year Collaboration Agreement With The University Of Virginia To Advance Type 1 And Type 2 Diabetes Research Benzinga

08:34AM EDT Dexcom Signs Agreement With The University Of Virginia to Advance Type 1 And Type 2 Diabetes Research RTTNews

08:30AM EDT Dexcom Signs Multi-Year Collaboration Agreement with the University of Virginia to Advance Type 1 and Type 2 Diabetes Research Business Wire

Sep 22, 2020

08:34AM EDT DexCom Reports G6 Continuous Glucose Monitoring System Now Available At Veterans Affairs Pharmacies Across The US Benzinga

08:30AM EDT Dexcom G6 Continuous Glucose Monitoring System Now Available at Veterans Affairs Pharmacies Across the United States Business Wire

Sep 16, 2020

08:30AM EDT Dexcom Announces First-Ever Registry Dedicated to Tracking Outcomes of In-Hospital Real-Time CGM Use in Response to the COVID-19 Pandemic Business Wire

Sep 4, 2020

08:45AM EDT Dexcom Announces Upcoming Virtual Conference Presentations Business Wire

Aug 12, 2020

08:41AM EDT DexCom Adds Karen Dahut To Its Board RTTNews

08:30AM EDT Dexcom Appoints Karen Dahut to Board of Directors Business Wire

Aug 10, 2020

04:05PM EDT Dexcom Announces Upcoming Conference Presentation Business Wire

Aug 6, 2020

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Jul 29, 2020

12:25PM EDT Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $465 Benzinga

11:37AM EDT UBS Maintains Neutral on DexCom, Raises Price Target to $400 Benzinga

10:38AM EDT Stifel Maintains Buy on DexCom, Raises Price Target to $500 Benzinga

09:35AM EDT Raymond James Maintains Outperform on DexCom, Raises Price Target to $450 Benzinga

08:33AM EDT Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $428 Benzinga

06:41AM EDT SVB Leerink Maintains Outperform on DexCom, Raises Price Target to $485 Benzinga

Jul 28, 2020

04:42PM EDT Recap: DexCom Q2 Earnings Benzinga

04:13PM EDT DexCom Q2 EPS $0.79 Beats $0.35 Estimate, Sales $451.80M Beat $415.39M Estimate Benzinga

04:13PM EDT DexCom Q2 EPS $0.79 May Not Compare To $0.35 Estimate, Sales $451.80M Beat $415.39M Estimate Benzinga

04:03PM EDT Dexcom Reports Second Quarter 2020 Financial Results Business Wire

04:05AM EDT Earnings Scheduled For July 28, 2020 Benzinga

Jul 16, 2020

10:23AM EDT Health Canada Authorizes Interim Use Of Dexcom G6 CGM By Pregnant Women In Response To Coronavirus Pandemic Benzinga

10:19AM EDT Health Canada Authorizes Interim Use of Dexcom G6 CGM by Pregnant Women in PR Newswire

document.getElementById("ZD0n71").onerror = function(){this.style.display='none';}; .dark-mode .dLN8jM{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .dLN8jM{ color: #333333; background-color: white; border: 2px solid #333333; }DXCMDexCom, Inc.stock NASDAQ

DXCM
DexCom, Inc.
stock NASDAQ